학술논문
Safety of heterologous ChAdOx1-S/BNT162b2 primary schedule versus homologous BNT162b2 vaccination: Insights from an Italian post-marketing study, 2021
Document Type
Article
Author
Source
In: Human Vaccines and Immunotherapeutics . (Human Vaccines and Immunotherapeutics, 2023, 19(1))
Subject
Language
English
ISSN
2164554X
21645515
21645515